Turku, Finland
Turku, Finland

Time filter

Source Type

Patent
Hormos Medical Ltd. | Date: 2015-08-21

This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.


Patent
Hormos Medical Ltd. | Date: 2011-01-19

This invention relates to a liquid or semisolid oral drug formulation comprising a therapeutically active compound of the formula (I)


The present invention concerns a method for the preparation of therapeutically valuable triphenylbutene derivatives, especially fispemifene.


Patent
Hormos Medical Ltd. | Date: 2014-01-24

This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof.


Patent
Hormos Medical Ltd. | Date: 2015-12-16

This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.


Patent
Hormos Medical Corporation | Date: 2014-01-30

This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.


Patent
Hormos Medical Corporation | Date: 2013-08-19

This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.


Patent
Hormos Medical LTD. | Date: 2013-05-29

This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.


Patent
Hormos Medical Corporation | Date: 2012-07-06

This invention relates to a method for enhancing the bioavailability of a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, wherein said compound is administered orally to the individual in connection with the intake of food.


The present invention concerns a method for the preparation of therapeutically valuable triphenylbutene derivatives, especially fispemifene.

Loading Hormos Medical Ltd. collaborators
Loading Hormos Medical Ltd. collaborators